Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies
- PMID: 9704887
- DOI: 10.1002/(SICI)1098-2396(199809)30:1<107::AID-SYN13>3.0.CO;2-1
Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies
Abstract
An unbiased place-preference conditioning procedure was used to characterize the conditioned reinforcing effects of phentermine (PHEN), fenfluramine (FEN), and their combination (PHEN/FEN) in previously drug-naive rats. Animals exhibited marked preferences for an environment previously associated with the administration of phentermine. The minimum dose producing a significant effect was 3.0 mg/kg. In contrast, FEN produced dose-related place aversions. In animals which received a subthreshold dose of FEN in combination with a dose of PHEN that produced a conditioned place preference, no preference or aversion for the drug-paired place was seen. Similarly, no significant conditioning in response to administration of PHEN (3.0 mg/kg) and FEN (3.0 mg/kg) was seen. The failure of PHEN/FEN to produce conditioned reinforcing effects is in line with recent clinical studies, and suggests that PHEN/FEN and drug combinations sharing the same neurochemical mechanisms of action will have low potential for abuse.
Similar articles
-
Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.Ann N Y Acad Sci. 1998 May 30;844:59-74. Ann N Y Acad Sci. 1998. PMID: 9668665
-
Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.Synapse. 1997 May;26(1):36-45. doi: 10.1002/(SICI)1098-2396(199705)26:1<36::AID-SYN4>3.0.CO;2-F. Synapse. 1997. PMID: 9097403
-
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.Synapse. 1998 Nov;30(3):239-46. doi: 10.1002/(SICI)1098-2396(199811)30:3<239::AID-SYN1>3.0.CO;2-C. Synapse. 1998. PMID: 9776127
-
Synergistic interactions between fenfluramine and phentermine.Int J Obes Relat Metab Disord. 1999 Jul;23(7):723-32. doi: 10.1038/sj.ijo.0800920. Int J Obes Relat Metab Disord. 1999. PMID: 10454106 Review.
-
Anesthetic considerations for the new antiobesity medications.AANA J. 1996 Dec;64(6):541-4. AANA J. 1996. PMID: 9204789 Review.
Cited by
-
Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens.Psychopharmacology (Berl). 2016 Apr;233(8):1405-13. doi: 10.1007/s00213-016-4231-z. Epub 2016 Feb 18. Psychopharmacology (Berl). 2016. PMID: 26887589
-
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.Exp Clin Psychopharmacol. 2008 Dec;16(6):458-74. doi: 10.1037/a0014103. Exp Clin Psychopharmacol. 2008. PMID: 19086767 Free PMC article. Review.
-
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.AAPS J. 2007 Jan 5;9(1):E1-10. doi: 10.1208/aapsj0901001. AAPS J. 2007. PMID: 17408232 Free PMC article. Review.
-
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.Drug Alcohol Depend. 2015 Feb 1;147:1-19. doi: 10.1016/j.drugalcdep.2014.12.005. Epub 2014 Dec 18. Drug Alcohol Depend. 2015. PMID: 25548026 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources